This is an old revision of this page, as edited by Bjornandersen86 (talk | contribs) at 01:44, 31 December 2024 (Page created. Contributions are welcome). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 01:44, 31 December 2024 by Bjornandersen86 (talk | contribs) (Page created. Contributions are welcome)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)The EFSD and the Novo Nordisk Foundation Precision Diabetes Medicine Award is an annual recognition established to support research in the field of precision diabetes medicine. The award is a joint initiative between the European Foundation for the Study of Diabetes (EFSD) and the Novo Nordisk Foundation. Its purpose is to advance the understanding and application of personalised approaches to diabetes care.
Objective and purpose of the award
The award seeks to facilitate the implementation of innovative and individualized treatment strategies and to promote advancements in precision medicine for diabetes care.
Award Structure
The program provides three awards annually:
- Winner: Receives DKK 2 million to support research over a three-year period.
- Two Runners-up: Each receives DKK 0.5 million for research funding over three years
Selection Process
Applications are evaluated by an independent ad hoc committee organized by the EFSD. The committee assesses submissions based on criteria such as scientific quality, innovation, and potential impact on diabetes care. Funding for the award is provided by the Novo Nordisk Foundation.
Review Criteria
The evaluation of applications is based on the following criteria:
- Significance: The relevance of the study to the program and its potential to advance scientific knowledge
- Approach: The development, integration, and appropriateness of the conceptual framework, design, methods, and analyses.
- Innovation: The degree to which the project incorporates novel concepts, approaches, or methods.
- Investigator: The qualifications and suitability of the investigator to execute the project.
- Environment: The contribution of the scientific environment to the project's success.
- Budget and Feasibility: The appropriateness of the requested budget and timeline for completing the project.
- Contribution to a Larger Research Project: If the application is part of a larger project, the clarity of its contribution to the overall objectives is assessed.
.
Previous award recipients:
| Year | Recipient | Associated institution |
|---|---|---|
| 2023 | Shivani Misra | Imperial College London - UK |
| 2023 | Eran Elinav | Weizmann Institute of Science - Rehovot, Israel |
| 2023 | Cyrielle Caussy | Lyon University Hospital Center - France |
| 2022 | Angus Jones | University of Exeter - UK |
| 2022 | Haifa Maalmi | German Diabetes Center - Düsseldorf, Germany |
| 2022 | Jørgen Wojtaszewski | University of Copenhagen - Denmark |
| 2021 | Charlotte Ling | Lund University - Malmo, Sweden |
| 2021 | Caroline Bonner | Institut Pasteur de Lille - Franc |
| 2021 | Thomas Pieber | Medical University of Graz - Austria |
References
- ^ "EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award Programme | EFSD". www.europeandiabetesfoundation.org. Retrieved 2024-12-31.
- "The EFSD and the Novo Nordisk Foundation Precision Diabetes Medicine Award". Novo Nordisk Fonden. Retrieved 2024-12-31.
- "EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award Programme 2022 | IRB Barcelona". www.irbbarcelona.org. Retrieved 2024-12-31.
- "EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award Programme - Research grants - IISPV". Retrieved 2024-12-31.
- "EFSD-NNF Precision Diabetes Medicine Award Programme | EFSD". www.europeandiabetesfoundation.org. Retrieved 2024-12-31.